Differing relationships of methylene tetrahydrofolate reductase genotypes with cardiovascular risk in familial and polygenic hypercholesterolaemia

European Journal of Preventive Cardiology

Volumn 7, Issue 6, 2000, Pages 431-434

  Wierzbicki, Anthony S ^a   Lambert Hammill, Michelle ^a   Junadi, Elizabeth ^a   Lumb, Peter J ^a   Crook, Martin A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

coronary heart disease; familial hypercholesterolaemia; homocysteine; methylene tetrahydrofolate reductase; polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIFACTORIAL INHERITANCE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; CORONARY DISEASE; FEMALE; GENOTYPE; HOMOCYSTEINE; HUMANS; HYPERCHOLESTEROLEMIA; LOGISTIC MODELS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MULTIFACTORIAL INHERITANCE; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; RISK FACTORS;

EID: 84992903580     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/204748730000700607     Document Type: Article

References (17)

1. Graham IM, Daly LE, Refsum H, Robinson K, Brattstrom LE, Ueland PM, et al Plasma homocysteine as a risk factor for vascular disease. JAMA 1997; 277: 1775–1781.
2. Wilcken DEL Novel risk factors for vascular disease: the homocysteine hypothesis of cardiovascular disease. J Cardiovasc Risk 1998; 5: 217–221.
3. Danesh J, Lewington S. Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies. J Cardiovasc Risk 1998; 5: 229–232.
4. Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ 1991; 303: 893–896.
5. Mansen PS, Rudiger N, Tybaerg-Hansen A, Faergeman O, Gregersen N. Detection of the apoB3500 (glutamine for arginine) by gene amplification and cleavage with Mspl. J Lipid Res 1991; 32: 1229–1233.
6. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al A candidate genetic risk factor for vascular disease; a common mutation in methylene tetrahydrofolate reductase. Nature Genet 1995; 10: 111–113.
7. Gerhard GT, Duell PB. Homocysteine and atherosclerosis. Curr Opin Lipidol 1999; 10: 417–428.
8. Nygard O, Vollset SE, Refsum H, Brattstrom L, Ueland PM. Total homocysteine and cardiovascular disease. J Intern Med 1999; 246: 425–454.
9. Brattstrom L, Wilcken DEL, Ogrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not vascular disease. Circulation 1998; 98: 2520–2526.
10. Mabuchi H, Koizumi J, Shimuzu M, Takeda R. Development of coronary heart disease in familial hypercholesterolaemia. Circulation 1989; 79: 225–232.
11. Domagala TB, Undas A, Libura M, Szozeklik A. Pathogenesis of vascular disease in hyperhomocysteinaemia. J Cardiovasc Risk 1998; 5: 239–247.
12. Defesche JC, Maduro EM, Wittekoek ME, Redeker EJW, Mannens MAMM, Kastelein JJP. Homocysteine is not an additional risk factor in familial hyper-cholesterolaemia [abstract]. in: European Atherosclerosis Society 70th Congress Conference Proceedings; 1998. p. 25.
13. Tonstad S, Refsum H, Ose L, Ueland P. The C677T mutation in the methylene-tetra-hydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolaemia treated with cholestyramine. J Paediatr 1998; 12: 365–368.
14. Sidhu PS, Naoumova RP, Maher VMG, MacSweeney JE, Neuwirth CKY, Hollyer JS, et al The extracranial carotid artery in familial hypercholesterolaemia: relationship of plasma lipids and coronary heart disease. J Cardiovasc Risk 1996; 3: 61–67.
15. Tonstad S, Refsum H, Ueland PM. Association between plasma homocysteine and parental history of cardiovascular disease in children with familial hypercholesterolaemia. Circulation 1997; 96: 1803–1808.
16. Raal FJ, Areias AJ, Waisberg R, Von Arb M. Susceptibility of low-density lipoprotein to oxidation in familial hypercholesterolaemia. Atherosclerosis 1995; 115: 9–15.
17. Raal FJ, Pilcher GJ, Waisberg R, Buthelezi EP, Veller MG, Joffe Bl. Low-density lipoprotein cholesterol bulk is the pivotal determinant of atherosclerosis in familial hypercholesterolemia. Am J Cardiol 1999; 83: 1330–1333.